|
| |
vaccinex rochester ny Pages on BioPortfolio:
BioPortfolio - Vaccinex Incorporated
Poxvirus expression vectors have gained widespread use for expression of... 24th August, 2004, Vaccinex, Inc, Rochester, New York, USA. Methods Mol Biol. ...
http://www.bioportfolio.com/biocorporate/10721-Vaccinex_Inco...
|
BioPortfolio - the biotechnology, pharmaceutical, life science and ...
BioPortfolio the comprehensive website for data, information, search engine and services on biotechnology, pharmaceutical and healthcare research, ...
http://www.bioportfolio.com/...
|
Results from other life science and pharmaceutical sites:
BioPortfolio - Vaccinex Incorporated
Poxvirus expression vectors have gained widespread use for expression of... 24th August, 2004, Vaccinex, Inc, Rochester, New York, USA. Methods Mol Biol. ...
http://www.bioportfolio.com/biocorporate/10721-Vaccinex_Inco...
|
Alliance Vaccinex
walter.eschenmoser@lonza.com Vaccinex, Inc. Stan Holland 1895 Mt. Hope Avenue Rochester, NY 14620 Tel +1 585.271.2700 Fax +1 585.271.2766 ...
http://www.lonza.com/group/en/company/news/archive/2003/lonz...
|
Vaccinex Antibody Licensed to GlaxoSmithKline
ROCHESTER, N.Y., Feb. 15 /PRNewswire/ -- EUSA Pharma (Oxford, UK), a Vaccinex collaboration partner, has announced that it has licensed OP-R003, ...
http://www.prnewswire.com/cgi-bin/stories.pl?ACCT=109&STORY=...
|
Vaccinex, Inc. Announces Award of Key Patent in Europe for its ...
ROCHESTER, N.Y., Nov. 30 /PRNewswire/ -- Vaccinex, Inc. announced today the award of a key European patent (European Patent No. 1340088) for its antibody
...
http://www.biospace.com/news_story.aspx?NewsEntityId=79038...
|
BioWorld Today
28 Feb 2007 ... "It's quite a unique target," said Raymond Watkins, vice president of operations for Rochester, N.Y.-based Vaccinex, adding that "a lot has ...
http://www.bioworld.com/servlet/com.accumedia.web.Dispatcher...
|
{1} And Biocon To Co-Develop Antibody Pr - News, Search Jobs ...
ROCHESTER, N.Y. and BANGALORE, India, Nov. 18 /PRNewswire/ -- Vaccinex, Inc. and Biocon Limited today announced a broad strategic partnership to discover ...
http://www.biospace.com/news_story.aspx?NewsEntityId=1818582...
|
Business Alliances - Research Alliances - James P Wilmot Cancer ...
Lucid, Inc. is a Rochester, NY-based company and a leader in developing ... Vaccinex’s proprietary technology offers diverse applications including antigen
...
http://www.urmc.rochester.edu/cancer-center/researchers/rese...
|
Table 5 : India's health biotech sector at a crossroads : Nature ...
Biocon, Co-development of human antibodies with Vaccinex (Rochester, NY US). Co- development of oral insulin with Nobex (Research Triangle Park, NC, US), ...
http://www.nature.com/nbt/journal/v25/n4/fig_tab/nbt0407-403...
|
Connections: The University of Rochester and the Community
Rochester-based companies such as Vaccinex, VirtualScopics, Socratech, Koning, ... a record $114 million in economic development for New York State in 2006.
...
http://www.rochester.edu/aboutus/connections/development.htm...
|
Article : Challenges Remain for Antibody Products Genetic ...
Vaccinex, based in Rochester, NY, is a privately held company focusing on a novel production method for generating fully human Mabs through use of a ...
http://www.genengnews.com/articles/chitem.aspx?aid=941&chid=...
|
|
